TORONTO, March 26, 2013 /CNW/ - Biosenta, Inc. (CNSX: ZRO) (the
"Company"), is focused on developing and deploying anti-microbial
products and remediation solutions to the market space for retail,
institutional and industrial users. The Company is pleased to announce
that Mr. Scott Butterworth, a seasoned marketing executive, has been
appointed as the Company's Vice-President Marketing and Sales.
"We are delighted to have someone of Mr. Butterworth's caliber and
experience step up to lead the Zeromold marketing and sales strategy,"
said Bruce Lewis, Chairman of the Board. "We are at a critical juncture
in the market and we need focused leadership to successfully implement
our strategy and maximize our market penetration. Mr. Butterworth is a
marketing executive with a proven entrepreneurial track record. He has
a deep understanding of our space and of the media technologies that
command consumer attention."
Previously, Mr. Butterworth has held several senior management positions
over the years where he was responsible for new business development
and account management, media buying and placement, the management of
interactive and offline sales teams for many high profile product
clients. He was National Account Manager for Procter and Gamble and
Coca Cola Bottling Canada. As Director of Business Development at News
Canada Marketing he encompassed the mass, grocery, specialty, drug and
convenience sectors. At Alea Retail services he led a field staff of
500 personnel. Most recently, Mr. Butterworth has held senior
management positions with such companies as Canada1 Sales and
Marketing, Empirical Integrated Marketing, ECO Environmental
Communications and Sabre Online. Mr. Butterworth studied Commerce at
the University of Toronto.
"I am delighted to be joining this dynamic company at an important time
of market inflection. The majority of North American people have
little, if any, knowledge of the health and environmental problems
generated by black mould. It is Biosenta's responsibility to raise
these concerns and to educate the public " said Mr. Butterworth."
About BIOSENTA Inc.
BIOSENTA Inc.'s line of retail anti-microbial products will effectively
kill mould, bacteria and fungi on contact and prevent re-growth. These
products address the demand created by the mounting health and
environmental concerns. Mould can affect the immune system, nervous
system, liver, kidneys, blood and cause brain damage.
BIOSENTA will also manufacture and distribute an anti-microbial filler.
Calcium Carbonate is one of the most common fillers used industrially.
It is susceptible like other fillers that hold moisture to attracting
mould. Annual global revenue in the calcium carbonate filler industry
approximates 140 billion dollars. BIOSENTA will produce anti-microbial
filler that performs 'filling' and 'bulking' functions like calcium
carbonate. BIOSENTA's filler product will not attract moisture and
consequently mould infestation. BIOSENTA's filler with its
anti-microbial high pH core in individual particles will enhance
commercial product life and eradicate a broad spectrum of known
bacteria, fungi, algae and other micro-organisms by suppression of
This release may contain forward-looking statements information and
statements which constitute "forward-looking information" under
Canadian securities law and which may be material regarding, among
other things, the Company's beliefs, plans, objectives, estimates,
intentions and expectations with respect to its capital and funding
plans. Inherent in the forward-looking information and statements are
known and unknown risks, uncertainties and other factors beyond the
Company's ability to control or predict, which give rise to the
possibility that the Company's predictions, forecasts, expectations or
conclusions will not prove to be accurate, that its assumptions may not
be correct and that the Company's plans, objectives and statements will
not be achieved. Actual results or developments may differ materially
from those contemplated by the forward-looking information and
statements. Consequently, undue reliance should not placed on such
On behalf of the Board of Directors of BIOSENTA Inc.
The CNSX has in no way passed upon the merits of the proposed
transaction and has neither approved nor disapproved of the contents of
this press release. Neither the CNSX nor its Regulation Services
Provider (as such term is defined in the policies of the CNSX) accepts
responsibility for the adequacy or accuracy of this release.
SOURCE: BIOSENTA Inc.
For further information:
Bruce Lewis, President & Chief Executive Officer
1120 Finch Avenue West, Suite 503,
Toronto, Ontario M3J 3H7
(416) 410 2019
Investor Relations contact:
Investor Cubed Inc.